For every 10,000 compounds that enter the drug discovery pipeline, only one will survive to be an approved drug.
80-90% of pre-clinical research projects fail before they get tested in humans.
It takes, on average, 15 years to turn a scientific discovery in the lab into a medicine patients can use.
We now spend roughly $100 billion a year on research and development from public- and private-sector sources combined. And yet only 35 new drugs were approved in 2011, up from 22 in 2010.
Only 5 cents of every U.S. health dollar goes to medical research.
It takes more than a billion dollars to bring one new therapy from lab to market.
1 in 3 Americans lives with a deadly or debilitating disease for which there are no cures and few meaningful treatment options.
Every 68 seconds someone is diagnosed with Alzheimer’s disease, every 24 seconds someone is diagnosed with cancer, every 18 seconds someone is diagnosed with diabetes, and the list goes on...
Only 50% of drugs in Phase III clinical trials becomes approved medicines.
9 of the top 10 causes of death in the U.S. have genetic components.
Nearly half (40%) of cancer clinical trials fail to accrue enough patients to complete the trial.
80% of cancer researchers limit the types of research they pursue due to lack of sufficient, high-quality specimens.
The average cost of all R&D prior to clinical development is $376 million for traditional pharmaceuticals and $615 million for biological products.
It takes 6 months to 2 years for a new drug to go through the FDA’s approval process.